Longevity Health Stock (NASDAQ:XAGE)
Previous Close
$0.29
52W Range
$0.29 - $14.10
50D Avg
$0.41
200D Avg
$2.03
Market Cap
$430.29K
Avg Vol (3M)
$3.24K
Beta
0.37
Div Yield
-
XAGE Company Profile
Longevity Health Holdings Inc focuses on the development of plasma-based bioactive material (PBM) to stimulate tissue repair or growth after injury, disease, and aging. Its lead product candidate is CT-101 bone healing accelerant for tibia fracture healing, foot/ankle fusion, spinal fusion, dental bone graft substitute, and bone void filler; and tissue healing accelerant for androgenetic alopecia and chronic wound healing. The company was founded in 2008 and is based in Pittsburgh, Pennsylvania.